Vor Biopharma Inc.

NASDAQ:VOR

0.16 (USD) • At close May 8, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024202320222021202020192018
Operating Activities:
Net Income -116.914-117.863-92.094-68.899-43.337-10.839-4.152
Depreciation & Amortization 3.5283.4922.5251.4340.6050.0910.02
Deferred Income Tax 00000-0.0320.289
Stock Based Compensation 9.84713.36210.6954.3151.3420.1720.116
Change In Working Capital 0.0050.65-12.693-9.1854.3160.1450.063
Accounts Receivables 0000000
Inventory 0000000
Accounts Payables 02.8500.4055.821.2120.065
Other Working Capital 0.005-2.2-12.693-9.59-1.504-1.0670.063
Other Non Cash Items 3.8740.0676.4233.1910.7820.6081.003
Operating Cash Flow -99.66-100.292-85.144-69.144-36.292-9.855-2.661
Investing Activities:
Investments In Property Plant And Equipment -0.229-1.069-8.462-3.894-4.161-0.7480
Acquisitions Net 0000000
Purchases Of Investments -9.914-74.923-123.189-87.757000
Sales Maturities Of Investments 10714737.560000
Other Investing Activites 00-0-0.088000
Investing Cash Flow 96.85771.008-94.091-91.651-4.161-0.7480
Financing Activities:
Debt Repayment 0000002.464
Common Stock Issued 55.8254.578115.975189.19882.26717.6990
Common Stock Repurchased 0000000
Dividends Paid 0000000
Other Financing Activities -2.433-1.641.16543.71382.52617.6990
Financing Cash Flow 53.3922.938117.14232.91182.52617.6992.464
Other Information:
Effect Of Forex Changes On Cash 0000000
Net Change In Cash 50.589-26.346-62.09572.11642.0737.096-0.197
Cash At End Of Period 84.36233.77360.119122.21450.0988.0250.929